Shopping Cart
- Remove All
- Your shopping cart is currently empty
TP-DEA2, a prodrug of triptolide, effectively inhibits bleomycin-induced pulmonary fibrosis and inflammatory responses. It significantly reduces the production of α-SMA.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
10 mg | Inquiry | Backorder | |
50 mg | Inquiry | Backorder |
Description | TP-DEA2, a prodrug of triptolide, effectively inhibits bleomycin-induced pulmonary fibrosis and inflammatory responses. It significantly reduces the production of α-SMA. |
In vitro | TP-DEA2 autonomously converts into triptolide (Triptolide, TP) without relying on enzymes. Additionally, TP-DEA2 can inhibit the expression of disintegrin and metalloproteinase 10 (ADAM 10) induced by transforming growth factor β1 (TGF-β1), and reduce the secretion of α-SMA in fibroblasts. |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.